StonvexLoading…
StonvexStonvexStonvexCore line items from GNLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $8.00K | $8.00K | $8.00K | $8.00K |
Operating Income | $-33.21M | $-31.70M | $-21.95M | $-15.01M |
Net Income | $-32.15M | $-29.87M | $-20.89M | $-6.58M |
EPS (Diluted) | $-0.86 | $-0.95 | $-0.69 | $-0.51 |
Total Assets | $19.03M | $34.72M | $40.27M | $45.18M |
Total Liabilities | $7.48M | $8.44M | $7.18M | $7.51M |
Cash & Equivalents | $5.33M | $8.56M | $6.10M | $7.86M |
Free Cash Flow OCF − CapEx | $-26.37M | $-21.61M | $-17.21M | $-11.44M |
Shares Outstanding | 38.14M | 34.73M | 34.54M | 34.51M |